Differentiation of Aseptic From Septic Loosening by 18F-fluoride PET

This study has been completed.
Sponsor:
Information provided by:
Yokohama City University Medical Center
ClinicalTrials.gov Identifier:
NCT01017562
First received: November 19, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
  Purpose

In this study, the investigators utilized the 18F-fluoride PET method to evaluate THA cases with a stable, septic or septic loosened implant in order to differentiate these clinical settings using a novel uptake type classification approach.


Condition
Hip Arthroplasty

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Differentiation of Aseptic From Septic Loosening in Patients With Total Hip Arthroplasty Using 18F-fluoride PET

Resource links provided by NLM:


Further study details as provided by Yokohama City University Medical Center:

Enrollment: 61
Study Start Date: April 2007
Study Completion Date: November 2009
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
condition of joint implant

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients after total hip arthroplasty who agreed with the informed consent for this study.

Criteria

Exclusion Criteria:

  • Within one year after surgery
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01017562

Locations
Japan
Departement of orthopaedic sugery
Yokohama, Kanagawa, Japan, 236-0004
Sponsors and Collaborators
Yokohama City University Medical Center
Investigators
Principal Investigator: Naomi Kobayashi, MD, PhD. Department of orthopaedic surgey, Yokohama City University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01017562     History of Changes
Other Study ID Numbers: YCU21-106
Study First Received: November 19, 2009
Last Updated: November 19, 2009
Health Authority: Japan: Institutional Review Board

Keywords provided by Yokohama City University Medical Center:
To clarify the 18F-fluoride uptake patterns associated with aseptic or septic loosening

Additional relevant MeSH terms:
Fluorides
Cariostatic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents

ClinicalTrials.gov processed this record on October 23, 2014